System Biology Approach to Identify the Hub Genes and Pathways Associated with Human H5N1 Infection.
H5N1 virus
KEGG pathways
avian influenza
gene ontology
hub genes
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
21 Jul 2023
21 Jul 2023
Historique:
received:
26
03
2023
revised:
27
04
2023
accepted:
13
05
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
H5N1 is a highly pathogenic avian influenza virus that can infect humans and has an estimated fatality rate of 53%. As shown by the current situation of the COVID-19 pandemic, emerging and re-emerging viruses such as H5N1 have the potential to cause another pandemic. Thus, this study outlined the hub genes and pathways associated with H5N1 infection in humans. The genes associated with H5N1 infection in humans were retrieved from the NCBI Gene database using "H5N1 virus infection" as the keyword. The genes obtained were investigated for protein-protein interaction (PPI) using STRING version 11.5 and studied for functional enrichment analysis using DAVID 2021. Further, the PPI network was visualised and analysed using Cytoscape 3.7.2, and the hub genes were obtained using the local topological analysis method of the cytoHubba plugin. A total of 39 genes associated with H5N1 infection in humans significantly interacted with each other, forming a PPI network with 38 nodes and 149 edges modulating 74 KEGG pathways, 76 biological processes, 13 cellular components, and 22 molecular functions. Further, the PPI network analysis revealed that 33 nodes interacted, forming 1056 shortest paths at 0.282 network density, along with a 1.947 characteristic path length. The local topological analysis predicted IFNA1, IRF3, CXCL8, CXCL10, IFNB1, and CHUK as the critical hub genes in human H5N1 infection. The hub genes associated with the H5N1 infection and their pathways could serve as diagnostic, prognostic, and therapeutic targets for H5N1 infection among humans.
Identifiants
pubmed: 37515084
pii: vaccines11071269
doi: 10.3390/vaccines11071269
pmc: PMC10385284
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Physiol. 1998 Sep;275(3):L611-21
pubmed: 9728057
Int J Mol Sci. 2017 Aug 07;18(8):
pubmed: 28783091
Am J Pathol. 2008 May;172(5):1155-70
pubmed: 18403604
Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3799-804
pubmed: 24572573
FASEB J. 2020 Oct;34(10):13156-13170
pubmed: 32860267
Annu Rev Immunol. 1990;8:253-78
pubmed: 2188664
Vet Q. 2022 Dec;42(1):167-171
pubmed: 35993230
Virulence. 2022 Dec;13(1):502-513
pubmed: 35300578
Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2479-88
pubmed: 24780373
QJM. 2023 Jul 28;116(7):594-596
pubmed: 36448691
J Recept Signal Transduct Res. 2015;35(6):600-4
pubmed: 26096166
Front Immunol. 2020 Dec 04;11:603337
pubmed: 33343577
J Virol. 2008 Nov;82(22):11294-307
pubmed: 18787012
Scand J Immunol. 2021 Mar;93(3):e12986
pubmed: 33043473
QJM. 2023 Feb 24;116(2):150-152
pubmed: 36469349
Vaccines (Basel). 2023 Jan 19;11(2):
pubmed: 36851099
Front Immunol. 2021 Jul 14;12:692700
pubmed: 34335603
Nucleic Acids Res. 2022 Jul 5;50(W1):W216-W221
pubmed: 35325185
J Immunol. 2009 Jan 15;182(2):1088-98
pubmed: 19124752
BMC Med. 2020 Dec 2;18(1):377
pubmed: 33261599
Front Immunol. 2022 Jul 05;13:951614
pubmed: 35865527
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Immunotargets Ther. 2020 Feb 26;9:13-30
pubmed: 32161726
J Virol. 2020 Jun 16;94(13):
pubmed: 32321815
Viruses. 2012 Sep;4(9):1438-76
pubmed: 23170167
EFSA J. 2021 Dec 23;19(12):e07108
pubmed: 34987626
J Virol. 2007 Nov;81(22):12439-49
pubmed: 17855549
Cytokine Growth Factor Rev. 2011 Jun;22(3):121-30
pubmed: 21802343
Viruses. 2022 Jul 26;14(8):
pubmed: 35893690
Cell Death Dis. 2018 Sep 25;9(10):1002
pubmed: 30254192
Lancet. 2004 Feb 21;363(9409):617-9
pubmed: 14987888
Immunity. 2007 Oct;27(4):549-59
pubmed: 17967410
New Microbes New Infect. 2022 Nov 29;49-50:101060
pubmed: 36504911
Virol J. 2007 Dec 05;4:134
pubmed: 18053252
Immunity. 2011 May 27;34(5):637-50
pubmed: 21616434
Expert Rev Vaccines. 2013 Jul;12(7):767-77
pubmed: 23885822
N Engl J Med. 2008 Jan 17;358(3):261-73
pubmed: 18199865
Nat Immunol. 2016 Sep 20;17(10):1142-9
pubmed: 27648547
Emerg Infect Dis. 2008 Nov;14(11):1819-21
pubmed: 18976586
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Emerg Infect Dis. 2007 May;13(5):708-12
pubmed: 17553248
PeerJ. 2020 May 27;7:e7954
pubmed: 32518710
Respir Res. 2005 Nov 11;6:135
pubmed: 16283933
Mol Immunol. 2013 Dec;56(4):705-19
pubmed: 23933511
J Virol. 2000 Jul;74(13):6015-20
pubmed: 10846083
DNA Cell Biol. 2019 Dec;38(12):1444-1451
pubmed: 31651197
J Virol. 2004 Sep;78(18):9954-64
pubmed: 15331729